ID   SIAE_HUMAN              Reviewed;         523 AA.
AC   Q9HAT2; B3KPB0; Q8IUT9; Q9HAU7; Q9NT71;
DT   11-OCT-2005, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2001, sequence version 1.
DT   10-MAY-2017, entry version 118.
DE   RecName: Full=Sialate O-acetylesterase;
DE            EC=3.1.1.53;
DE   AltName: Full=H-Lse;
DE   AltName: Full=Sialic acid-specific 9-O-acetylesterase;
DE   Flags: Precursor;
GN   Name=SIAE; Synonyms=YSG2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2), SUBCELLULAR LOCATION,
RP   AND TISSUE SPECIFICITY.
RC   TISSUE=Testis;
RX   PubMed=15292578; DOI=10.1155/S1110724304307084;
RA   Zhu H., Chan H.C., Zhou Z., Li J.M., Zhu H., Yin L., Xu M., Cheng L.,
RA   Sha J.H.;
RT   "A gene encoding sialic-acid-specific 9-O-acetylesterase found in
RT   human adult testis.";
RL   J. Biomed. Biotechnol. 2004:130-136(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Hypothalamus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 3-523 (ISOFORM 1).
RC   TISSUE=Amygdala;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [6]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-401 AND ASN-422.
RC   TISSUE=Liver;
RX   PubMed=19159218; DOI=10.1021/pr8008012;
RA   Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.;
RT   "Glycoproteomics analysis of human liver tissue by combination of
RT   multiple enzyme digestion and hydrazide chemistry.";
RL   J. Proteome Res. 8:651-661(2009).
RN   [7]
RP   SUBCELLULAR LOCATION, VARIANTS AIS6 PHE-196; ARG-212; TRP-230;
RP   GLY-266; PRO-309; CYS-349; HIS-393; SER-404 AND CYS-479, VARIANTS
RP   GLY-3; SER-33; HIS-62; SER-64; ARG-71; VAL-89; LYS-161; MET-312;
RP   HIS-314; ASN-400; ARG-447; ILE-456 AND ARG-462, CHARACTERIZATION OF
RP   VARIANTS AIS6 PHE-196; ARG-212; TRP-230; GLY-266; PRO-309; CYS-349;
RP   HIS-393; SER-404 AND CYS-479, AND CHARACTERIZATION OF VARIANTS GLY-3;
RP   SER-33; HIS-62; SER-64; VAL-89; LYS-161; MET-312; HIS-314; ASN-400;
RP   ARG-447; ILE-456 AND ARG-462.
RX   PubMed=20555325; DOI=10.1038/nature09115;
RA   Surolia I., Pirnie S.P., Chellappa V., Taylor K.N., Cariappa A.,
RA   Moya J., Liu H., Bell D.W., Driscoll D.R., Diederichs S., Haider K.,
RA   Netravali I., Le S., Elia R., Dow E., Lee A., Freudenberg J.,
RA   De Jager P.L., Chretien Y., Varki A., Macdonald M.E., Gillis T.,
RA   Behrens T.W., Bloch D., Collier D., Korzenik J., Podolsky D.K.,
RA   Hafler D., Murali M., Sands B., Stone J.H., Gregersen P.K., Pillai S.;
RT   "Functionally defective germline variants of sialic acid
RT   acetylesterase in autoimmunity.";
RL   Nature 466:243-247(2010).
RN   [8]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
CC   -!- FUNCTION: Catalyzes the removal of O-acetyl ester groups from
CC       position 9 of the parent sialic acid, N-acetylneuraminic acid.
CC   -!- CATALYTIC ACTIVITY: N-acetyl-O-acetylneuraminate + H(2)O = N-
CC       acetylneuraminate + acetate.
CC   -!- SUBCELLULAR LOCATION: Lysosome {ECO:0000305}. Secreted.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q9HAT2-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9HAT2-2; Sequence=VSP_018993;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Widely expressed with high expression in the
CC       testis, prostate, and colon. {ECO:0000269|PubMed:15292578}.
CC   -!- DISEASE: Autoimmune disease 6 (AIS6) [MIM:613551]: Individuals
CC       manifesting susceptibility to autoimmune disease type 6 can suffer
CC       from juvenile idiopathic arthritis, rheumatoid arthritis, multiple
CC       sclerosis, Sjogren syndrome, systemic lupus erythematosus, type 1
CC       diabetes, ulcerative colitis, and Crohn disease.
CC       {ECO:0000269|PubMed:20555325}. Note=Disease susceptibility is
CC       associated with variations affecting the gene represented in this
CC       entry.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF300796; AAG15386.1; -; mRNA.
DR   EMBL; AF303378; AAG14897.1; -; mRNA.
DR   EMBL; AK056093; BAG51622.1; -; mRNA.
DR   EMBL; CH471065; EAW67591.1; -; Genomic_DNA.
DR   EMBL; BC068450; AAH68450.1; -; mRNA.
DR   EMBL; AL137496; CAB70771.1; -; mRNA.
DR   CCDS; CCDS55795.1; -. [Q9HAT2-2]
DR   CCDS; CCDS8449.1; -. [Q9HAT2-1]
DR   PIR; T46250; T46250.
DR   RefSeq; NP_001186851.1; NM_001199922.1. [Q9HAT2-2]
DR   RefSeq; NP_733746.1; NM_170601.4. [Q9HAT2-1]
DR   UniGene; Hs.10056; -.
DR   ProteinModelPortal; Q9HAT2; -.
DR   BioGrid; 119945; 53.
DR   IntAct; Q9HAT2; 1.
DR   STRING; 9606.ENSP00000263593; -.
DR   iPTMnet; Q9HAT2; -.
DR   PhosphoSitePlus; Q9HAT2; -.
DR   BioMuta; SIAE; -.
DR   DMDM; 74734243; -.
DR   EPD; Q9HAT2; -.
DR   MaxQB; Q9HAT2; -.
DR   PaxDb; Q9HAT2; -.
DR   PeptideAtlas; Q9HAT2; -.
DR   PRIDE; Q9HAT2; -.
DR   DNASU; 54414; -.
DR   Ensembl; ENST00000263593; ENSP00000263593; ENSG00000110013. [Q9HAT2-1]
DR   Ensembl; ENST00000545756; ENSP00000437877; ENSG00000110013. [Q9HAT2-2]
DR   Ensembl; ENST00000618733; ENSP00000478211; ENSG00000110013. [Q9HAT2-2]
DR   GeneID; 54414; -.
DR   KEGG; hsa:54414; -.
DR   UCSC; uc001qan.4; human. [Q9HAT2-1]
DR   CTD; 54414; -.
DR   DisGeNET; 54414; -.
DR   GeneCards; SIAE; -.
DR   HGNC; HGNC:18187; SIAE.
DR   HPA; HPA038052; -.
DR   HPA; HPA038053; -.
DR   MalaCards; SIAE; -.
DR   MIM; 610079; gene.
DR   MIM; 613551; phenotype.
DR   neXtProt; NX_Q9HAT2; -.
DR   OpenTargets; ENSG00000110013; -.
DR   PharmGKB; PA142670922; -.
DR   eggNOG; ENOG410IGS1; Eukaryota.
DR   eggNOG; ENOG410XQ2Q; LUCA.
DR   GeneTree; ENSGT00390000010608; -.
DR   HOGENOM; HOG000065687; -.
DR   HOVERGEN; HBG007955; -.
DR   InParanoid; Q9HAT2; -.
DR   KO; K05970; -.
DR   OMA; WLPASMN; -.
DR   OrthoDB; EOG091G04JT; -.
DR   PhylomeDB; Q9HAT2; -.
DR   TreeFam; TF328611; -.
DR   ChiTaRS; SIAE; human.
DR   GenomeRNAi; 54414; -.
DR   PRO; PR:Q9HAT2; -.
DR   Proteomes; UP000005640; Chromosome 11.
DR   Bgee; ENSG00000110013; -.
DR   CleanEx; HS_SIAE; -.
DR   Genevisible; Q9HAT2; HS.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0005615; C:extracellular space; IDA:UniProtKB.
DR   GO; GO:0005764; C:lysosome; IEA:UniProtKB-SubCell.
DR   GO; GO:0001681; F:sialate O-acetylesterase activity; IDA:UniProtKB.
DR   GO; GO:0005975; P:carbohydrate metabolic process; IDA:UniProtKB.
DR   GO; GO:0002682; P:regulation of immune system process; IMP:UniProtKB.
DR   InterPro; IPR005181; SASA.
DR   InterPro; IPR013830; SGNH_hydro.
DR   Pfam; PF03629; SASA; 1.
DR   SUPFAM; SSF52266; SSF52266; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Complete proteome; Disease mutation;
KW   Glycoprotein; Hydrolase; Lysosome; Polymorphism; Reference proteome;
KW   Secreted; Serine esterase; Signal.
FT   SIGNAL        1     23       {ECO:0000255}.
FT   CHAIN        24    523       Sialate O-acetylesterase.
FT                                /FTId=PRO_0000042241.
FT   CARBOHYD    107    107       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    138    138       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    267    267       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    290    290       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    401    401       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:19159218}.
FT   CARBOHYD    422    422       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:19159218}.
FT   VAR_SEQ       1     35       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:15292578}.
FT                                /FTId=VSP_018993.
FT   VARIANT       3      3       A -> G (rare variant found in a patient
FT                                with Crohn disease; probably not involved
FT                                in disease susceptibility; the mutant
FT                                enzyme has normal activity and is
FT                                normally secreted; dbSNP:rs144571829).
FT                                {ECO:0000269|PubMed:20555325}.
FT                                /FTId=VAR_064438.
FT   VARIANT      33     33       N -> S (rare variant found in a patient
FT                                with rheumatoid arthritis; probably not
FT                                involved in disease susceptibility; the
FT                                mutant enzyme has normal activity and is
FT                                normally secreted; dbSNP:rs762824510).
FT                                {ECO:0000269|PubMed:20555325}.
FT                                /FTId=VAR_064439.
FT   VARIANT      62     62       R -> H (the mutant enzyme has normal
FT                                activity and is normally secreted;
FT                                dbSNP:rs377634657).
FT                                {ECO:0000269|PubMed:20555325}.
FT                                /FTId=VAR_064440.
FT   VARIANT      64     64       G -> S (the mutant enzyme has normal
FT                                activity and is normally secreted;
FT                                dbSNP:rs76655561).
FT                                {ECO:0000269|PubMed:20555325}.
FT                                /FTId=VAR_064441.
FT   VARIANT      71     71       K -> R (in dbSNP:rs12282107).
FT                                {ECO:0000269|PubMed:20555325}.
FT                                /FTId=VAR_051356.
FT   VARIANT      89     89       M -> V (polymorphism that at homozygosity
FT                                may predispose to autoimmunity; normal
FT                                enzyme activity; dbSNP:rs78778622).
FT                                {ECO:0000269|PubMed:20555325}.
FT                                /FTId=VAR_064442.
FT   VARIANT     161    161       Q -> K (the mutant enzyme has normal
FT                                activity and is normally secreted;
FT                                dbSNP:rs200739060).
FT                                {ECO:0000269|PubMed:20555325}.
FT                                /FTId=VAR_064443.
FT   VARIANT     196    196       C -> F (in AIS6; defective enzyme
FT                                secretion and activity;
FT                                dbSNP:rs143070599).
FT                                {ECO:0000269|PubMed:20555325}.
FT                                /FTId=VAR_064444.
FT   VARIANT     212    212       G -> R (in AIS6; defective enzyme
FT                                secretion and activity;
FT                                dbSNP:rs149466359).
FT                                {ECO:0000269|PubMed:20555325}.
FT                                /FTId=VAR_064445.
FT   VARIANT     230    230       R -> W (in AIS6; defective enzyme
FT                                secretion and activity;
FT                                dbSNP:rs200862001).
FT                                {ECO:0000269|PubMed:20555325}.
FT                                /FTId=VAR_064446.
FT   VARIANT     266    266       C -> G (in AIS6; defective enzyme
FT                                secretion and activity;
FT                                dbSNP:rs746914032).
FT                                {ECO:0000269|PubMed:20555325}.
FT                                /FTId=VAR_064447.
FT   VARIANT     309    309       Q -> P (in AIS6; defective enzyme
FT                                secretion and activity;
FT                                dbSNP:rs757586703).
FT                                {ECO:0000269|PubMed:20555325}.
FT                                /FTId=VAR_064448.
FT   VARIANT     312    312       T -> M (may predispose to autoimmunity;
FT                                defective enzyme secretion and activity;
FT                                dbSNP:rs144510878).
FT                                {ECO:0000269|PubMed:20555325}.
FT                                /FTId=VAR_064449.
FT   VARIANT     314    314       R -> H (defective enzyme secretion and
FT                                activity; dbSNP:rs147649509).
FT                                {ECO:0000269|PubMed:20555325}.
FT                                /FTId=VAR_064450.
FT   VARIANT     349    349       Y -> C (in AIS6; defective enzyme
FT                                secretion and activity;
FT                                dbSNP:rs749579541).
FT                                {ECO:0000269|PubMed:20555325}.
FT                                /FTId=VAR_064451.
FT   VARIANT     393    393       R -> H (in AIS6; defective enzyme
FT                                secretion and activity;
FT                                dbSNP:rs552372846).
FT                                {ECO:0000269|PubMed:20555325}.
FT                                /FTId=VAR_064452.
FT   VARIANT     400    400       K -> N (rare variant found in a patient
FT                                with Crohn disease; probably not involved
FT                                in disease susceptibility; the mutant
FT                                protein has normal activity;
FT                                dbSNP:rs766047951).
FT                                {ECO:0000269|PubMed:20555325}.
FT                                /FTId=VAR_064453.
FT   VARIANT     404    404       F -> S (in AIS6; defective enzyme
FT                                secretion and activity;
FT                                dbSNP:rs201877149).
FT                                {ECO:0000269|PubMed:20555325}.
FT                                /FTId=VAR_064454.
FT   VARIANT     447    447       H -> R (the mutant enzyme has normal
FT                                activity and is normally secreted;
FT                                dbSNP:rs147161431).
FT                                {ECO:0000269|PubMed:20555325}.
FT                                /FTId=VAR_064455.
FT   VARIANT     456    456       M -> I (the mutant enzyme has normal
FT                                activity and is normally secreted).
FT                                {ECO:0000269|PubMed:20555325}.
FT                                /FTId=VAR_064456.
FT   VARIANT     462    462       Q -> R (the mutant enzyme has normal
FT                                activity and is normally secreted;
FT                                dbSNP:rs143668140).
FT                                {ECO:0000269|PubMed:20555325}.
FT                                /FTId=VAR_064457.
FT   VARIANT     467    467       A -> V (in dbSNP:rs7941523).
FT                                /FTId=VAR_051357.
FT   VARIANT     479    479       R -> C (in AIS6; defective enzyme
FT                                secretion and activity;
FT                                dbSNP:rs376857712).
FT                                {ECO:0000269|PubMed:20555325}.
FT                                /FTId=VAR_064458.
SQ   SEQUENCE   523 AA;  58315 MW;  B72CF69636DBFED8 CRC64;
     MVAPGLVLGL VLPLILWADR SAGIGFRFAS YINNDMVLQK EPAGAVIWGF GTPGATVTVT
     LRQGQETIMK KVTSVKAHSD TWMVVLDPMK PGGPFEVMAQ QTLEKINFTL RVHDVLFGDV
     WLCSGQSNMQ MTVLQIFNAT RELSNTAAYQ SVRILSVSPI QAEQELEDLV AVDLQWSKPT
     SENLGHGYFK YMSAVCWLFG RHLYDTLQYP IGLIASSWGG TPIEAWSSGR SLKACGVPKQ
     GSIPYDSVTG PSKHSVLWNA MIHPLCNMTL KGVVWYQGES NINYNTDLYN CTFPALIEDW
     RETFHRGSQG QTERFFPFGL VQLSSDLSKK SSDDGFPQIR WHQTADFGYV PNPKMPNTFM
     AVAMDLCDRD SPFGSIHPRD KQTVAYRLHL GARALAYGEK NLTFEGPLPE KIELLAHKGL
     LNLTYYQQIQ VQKKDNKIFE ISCCSDHRCK WLPASMNTVS TQSLTLAIDS CHGTVVALRY
     AWTTWPCEYK QCPLYHPSSA LPAPPFIAFI TDQGPGHQSN VAK
//
